Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.

JM, Ruiz-Moreno; JA, Montero; F, Gomez-Ulla; S, Ares

doi:10.1136/bjo.2008.145391

Public

Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.

Shared by NobleBlocks on Dec 17, 2008 • 12:00 AM UTC

Authors:

Ruiz-Moreno JM

Montero JA

Gomez-Ulla F

Abstract

Aims The aim of the study was to examine the changes in visual acuity, fluorescein angiography (FA) and optical coherence tomography (OCT) macular thickness of subfoveal, and juxtafoveal choroidal neovascularisation (CNV) in highly myopic eyes treated by intravitreal bevacizumab.Methods The study wa...

Discussions